Trials / Completed
CompletedNCT05893797
A Study of LY8888AX in Participants Using a Connected Insulin Management Platform
Assessment of Participant Adherence and Glucose Control While Using a Connected Insulin Management Platform
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to assess participant adherence and glucose control while using a connected insulin management platform. Approximately 50 participants will be enrolled in each country.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin Lispro | As prescribed. |
| DEVICE | Tempo Smart Button | Attached to the Tempo Pen |
| DEVICE | Dexcom G6 CGM | Continuous glucose monitor |
| DEVICE | Glooko Research Mobile App (RMA) | Installed on a study provided android phone. |
Timeline
- Start date
- 2023-10-05
- Primary completion
- 2024-09-16
- Completion
- 2024-09-16
- First posted
- 2023-06-08
- Last updated
- 2025-11-10
- Results posted
- 2025-11-10
Locations
9 sites across 1 country: France
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05893797. Inclusion in this directory is not an endorsement.